Publication

Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Melissa H. Bloodworth, Vanderbilt UniversityMark Rusznak, Vanderbilt UniversityConnor C. Pfister, Vanderbilt UniversityJian Zhang, Vanderbilt UniversityLisa Bastarache, Vanderbilt UniversitySandra Alvarez Calvillo, Vanderbilt UniversityJames D. Chappell, Vanderbilt UniversityKelli L. Boyd, Vanderbilt UniversityShinji Toki, Vanderbilt UniversityDawn C. Newcomb, Vanderbilt UniversityMatthew T. Stier, Vanderbilt UniversityWeisong Zhou, Vanderbilt UniversityKasia Goleniewska, Vanderbilt UniversityMartin Moore, Emory UniversityTina V. Hartert, Vanderbilt UniversityKevin D. Niswender, Vanderbilt UniversityR. Stokes Peebles, Vanderbilt University
Language
  • English
Date
  • 2018-08-01
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2018 American Academy of Allergy, Asthma & Immunology
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0091-6749
Volume
  • 142
Issue
  • 2
Start Page
  • 683
End Page
  • 687
Grant/Funding Information
  • The VUMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404).
  • The PheWAS study was supported by the National Center for Research Resources, Grant UL1 RR024975-01, and is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06.
Supplemental Material (URL)
Author Notes
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Virology

Tools

Relations

In Collection:

Items